Purdue has a new OxyContin formulation they say makes the pills impossible to crush and snort. Whether it’s true or not remains to be seen - the FDA panel responsible for it’s approval indicated that the scientific evidence of their claims is negligible. Not surprising - they had no real scientific evidence for the last formulation either. And that landed thousands in drug rehab.

Doctors all over the U.S. are turning to methadone as the primary painkiller - although plenty of people are in need of drug rehab for that, too - and Purdue Pharma is no doubt as freaked out about their big cash crop going down the drain as a farmer with an ice storm just before harvest season.

Will the new OxyContin be approved? Let’s hope not. While there are still thousands of people in the U.S. addicted to it who need drug rehab, at least its reputation has stopped it from being so widely prescribed. That gives us a little hope that the problem will eventually die out. If we open our arms to it again, we also open the door to more addiction problems.

Personally, I’m appalled that Purdue would make a move like this. But, really, it’s no surprise. What can you expect? The company’s losing a big chunk of change and, in the end, that’s all they really care about. They couldn’t give two hoots for the people who need a drug rehab program.  I couldn’t give two hoots about what happens to that company.

Popularity: 10% [?]